Advertisement

Topics

Pharmaceutical Product Development, LLC and NeoGenomics, Inc. Company Profile

10:27 EDT 21st August 2018 | BioPortfolio


News Articles [2009 Associated News Articles listed on BioPortfolio]

Expansion of global oncology testing for clinical trials

Pharmaceutical Product Development and NeoGenomics have formed a strategic alliance to provide global pathology and molecular testing solutions

NeoGenomics Reports Revenue of $67.8 Million on 18.7% Clinical Volume Growth and $10. ...

FT. MYERS, FL--(Marketwired - February 21, 2018) -NeoGenomics, Inc.( NASDAQ : NEO),a leading provider of cancer-focused genetic testing services, today reported Read more...

Public offering nets $117.5mm for NeoGenomics

NeoGenomics Inc. netted $117.5mm through a public offering of 9.8mm common shares at $12.75. The company offers genetic testing for cancer and companion diagnostic/pharma services, and will use the of...

Demand for pathology services sparks PPD, NeoGenomics alliance

PPD is teaming up with NeoGenomics Laboratories in response to increasingly complex clinical trials and demand for pathology services, says exec.

NeoGenomics Schedules its First Quarter Earnings Release for May 1, 2018

FT. MYERS, FL--(Marketwired - April 02, 2018) - NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services,announced today that it plans to release its first quart...

Investor Network: NeoGenomics, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / February 21, 2018 / NeoGenomics, Inc. (NASDAQ: NEO) will be discussing their earnings results in their Q4 Earnings Call to be held on February 21, 2018 at 10:00 AM Easte...

PPD and NeoGenomics Forming Global Strategic Alliance for Pathology and Molecular Testing Solutions

Expanding Global Oncology Testing for Clinical Trials Pharmaceutical Product Development, LLC (PPD), a leading global contract research organization (CRO), and

NeoGenomics Reports Record Revenue of $67.7 Million with 14% Increase in Clinical Volume Growth and 95% Increase in Pharma Services Backlog

NeoGenomics (NASDAQ:NEO) has announced its results for the second quarter of 2018. As quoted in the press release: Second Quarter 2018 Highlights: •  9% increase in consolidated revenue; 12% exclud...

PubMed Articles [2134 Associated PubMed Articles listed on BioPortfolio]

Continuous Manufacturing in Pharmaceutical Process Development and Manufacturing.

The pharmaceutical industry has found new applications for the use of continuous processing for the manufacture of new therapies currently in development. The transformation has been encouraged by reg...

Patient centric drug product design in modern drug delivery as an opportunity to increase safety and effectiveness.

The advances in drug delivery technologies have enabled pharmaceutical scientists to deliver a drug through various administration routes and optimize the drug release and absorption. The wide range o...

A tutorial for developing a topical cream formulation based on the Quality by Design approach.

The pharmaceutical industry has entered in a new era, as there is a growing interest in increasing the quality standards of dosage forms, through the implementation of more structured development and ...

Past, present and future of bioequivalence: Improving assessment and extrapolation of therapeutic equivalence for oral drug products.

The growth in the utilization of systems thinking principles has created a paradigm shift in the regulatory sciences and drug product development. Instead of relying extensively on end product testing...

Raw material variability of an active pharmaceutical ingredient and its relevance for processability in secondary continuous pharmaceutical manufacturing.

Active Pharmaceutical Ingredients (API) raw material variability is not always thoroughly considered during pharmaceutical process development, mainly due to low quantities of drug substance available...

Clinical Trials [3504 Associated Clinical Trials listed on BioPortfolio]

Clinical Bioequivalence Study on Two Metoprolol Tablet 100mg Formulations

The purpose of the study is to compare the bioavailability of a generic product of metoprolol with that of a reference product when administered to healthy volunteers under fasting conditi...

Clinical Bioequivalence Study on Two Amlodipine Tablet 10mg Formulations

The purpose of the study is to compare the bioavailability of a generic product of amlodipine with that of a reference product when administered to healthy volunteers under fasting conditi...

Clinical Bioequivalence Study on Two Gliclazide 80mg Tablet Formulations

The purpose of the study is to compare the bioavailability of a generic product of gliclazide (Product Name: BF-Gliclazide Tablet 80mg, Manufactured by Bright Future Pharmaceuticals Factor...

Clinical Bioequivalence Study on Two Lisinopril Tablets 20mg Formulations

The objective of the study is to compare the bioavailability of a generic product of lisinopril with that of a reference product when administered to healthy volunteers under fasting condi...

Clinical Bioequivalence Study on Two Methyldopa Tablet 250mg Formulations

The objective of the study is to compare the bioavailability of a generic product of methyldopa with that of a reference product when administered to healthy volunteers under fasting condi...

Companies [4433 Associated Companies listed on BioPortfolio]

Pharmaceutical Product Development, LLC and NeoGenomics, Inc.

Neogenomics

NeoGenomics Laboratories is a state of the art genetic testing facility headquartered in Fort Myers, Florida. NeoGenomics Laboratories offers testing in cancer genetics, flow cytometry and molecular d...

NeoGenomics, Inc.

NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory that specializes in cancer genetics diagnostic testing, the fastest growing segment of the laboratory industry. The company's...

DOV Pharmaceutical, Inc

DOV Pharmaceutical, Inc. is a biopharmaceutical company focused on the discovery, acquisition, development and commercialization of novel drug candidates for central nervous system, or CNS, disorders....

IriSys, Inc.

IriSys, Inc. was founded in 1996 by Gerald J. Yakatan, Ph.D. and Gina Stack with the goal of establishing a premier West Coast pharmaceutical product development contract services organization. After...

More Information about "Pharmaceutical Product Development, LLC and NeoGenomics, Inc." on BioPortfolio

We have published hundreds of Pharmaceutical Product Development, LLC and NeoGenomics, Inc. news stories on BioPortfolio along with dozens of Pharmaceutical Product Development, LLC and NeoGenomics, Inc. Clinical Trials and PubMed Articles about Pharmaceutical Product Development, LLC and NeoGenomics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Pharmaceutical Product Development, LLC and NeoGenomics, Inc. Companies in our database. You can also find out about relevant Pharmaceutical Product Development, LLC and NeoGenomics, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record